Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord

NeuroReport

Volumn 7, Issue 12, 1996, Pages 1973-1976

  Arvieu, Laurent ^a   Mauborgne, Annie ^a   Bourgoin, Sylvie ^a   Oliver, Charles ^b   Feltz, Paul ^c   Hamon, Michel ^a   Cesselin, François ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

calcitonin gene related peptide; dorsal spinal cord; in vitro release; substance P; sumatriptan

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; METITEPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN RECEPTOR; SUBSTANCE P; SUMATRIPTAN; TERTATOLOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; SPINAL CORD; TISSUE SLICE;

EID: 0029860966     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199608120-00023     Document Type: Article

References (25)

1. Hoyer D, Clarke DE, Fozard JR et al. Pharmacol Rev 46, 157-203 (1994).
2. Hamel E, Fan E, Linville D et al Mol Pharmacol 44, 242-246 (1993).
3. Humphrey PPA, Feniuk W and Perren MJ. Headache 30, 12-16 (1990).
4. Goadsby PJ and Edvinsson L. Ann Neurol 33, 48-56 (1993).
5. Moskowitz MA. Trends Pharmacol Sci 13, 307-311 (1992).
6. Bruinvels A, Landwehrmeyer M, Moskowitz MA et al. Eur J Pharmacol 227, 357-359 (1992).
7. Rebeck GW, Maynard KI, Hyman BT et al. Proc Natl Acad Sci USA 91, 3666-3669 (1994).
8. Doucet E, Pohl M, Fattaccini CM et al Synapse 19, 18-28 (1995).
9. Laporte AM, Fattaccini CM, Lombard MC et al. J Neural Transm (Gen Sect) 100, 207-223 (1995).
10. El-Yassir N, Fleetwood-Walker SM and Mitchell R. Brain Res 456, 147-158 (1988).
11. Murphy RM and Zemlan FP. Neuropharmacology 29, 463-468 (1990).
12. Hoyer D and Middlemiss DN. Trends Pharmacol Sci 10, 130-132 (1989).
13. Boschert U, Amara DA. Segu L et al. Neuroscience 58, 167-182 (1994).
14. Pohl M, Benoliel JJ, Bourgoin S et al J Neurochem 55, 1122-1130 (1990).
15. Malcangio M and Bowery NG. J Pharmacol Exp Ther 266, 1490-1496 (1993).
16. Pohl M, Lombard MC, Bourgoin S et al. Neuropeptides 14, 151-159 (1989).
17. Mauborgne A, Lutz O, Legrand JC et al. J Neurochem 48, 177-182 (1987).
18. Nagy JI. Handbook Psychopharmacol 15, 185-235 (1982).
19. Assié MB and Koek W. Neuropharmacology 35, 213-222 (1996).
20. Clitherow JW, Scopes DIC, Skingle M et al. J Med Chem 37, 2253-2257 (1994).
21. Fletcher A, Forster EA, Bill DJ et al. Behav Brain Res 73, 337-353 (1996).
22. Jolas T, Haj-Dhamane S, Lanfumey L et al. Naunyn-Schmiedeberg's Arch Pharmacol 347, 453-463 (1993).
23. Pauwels PJ and Colpaert FC Neuropharmacology 34, 235-237 (1995).
24. Kaube H, Hoskin KL and Goadsby PJ. Br J Pharmacol 109, 788-792 (1993).
25. Stein C. Anesth Analg 76, 182-191 (1993).